Coronavirus Vaccine Act

Bill: 117-s-286
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2021-02-08
Policy area: Health
Subjects: Cardiovascular and respiratory health

Emergency medical services and trauma care

Health programs administration and funding

Immunology and vaccination

Infectious and parasitic diseases

Medical research

Research administration and funding
Latest action: action_date: 2021-02-08
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2021-02-08
action_desc: Introduced in Senate
text: <p><b>Coronavirus Vaccine Act</b></p> <p>This bill directs the National Institute of Allergy and Infectious Diseases to conduct or support research to develop a universal coronavirus vaccine.</p>

tv_txt: II 117th CONGRESS 1st Session S. 286 IN THE SENATE OF THE UNITED STATES February 8, 2021 Mr. Markey introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To conduct or support further comprehensive research for the creation of a universal coronavirus vaccine.

1. Short title This Act may be cited as the Coronavirus Vaccine Act . 2. Research for the creation of a universal coronavirus vaccine (a) In general The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal coronavirus vaccine. (b) Authorization of appropriations To carry out this section, there are authorized to be appropriated $250,000,000 for each of fiscal years 2021 through 2024.